Beeke Wienert
Beeke earned her PhD in Molecular Genetics in 2016 from the University of New South Wales in Sydney, Australia, studying hemoglobinopathies and therapeutic upregulation of fetal hemoglobin using CRISPR. In 2017 she became a postdoctoral researcher at the Innovative Genomics Institute in the Bay Area and specializes in CRISPR-Cas9 off-target discovery and DNA repair as part of Jacob Corn’s team. In 2018 she joined Bruce Conklin’s team at the Gladstone Institutes in San Francisco to study rare genetic diseases using patient-derived stem cells as disease models. Her work focuses on the development of safe CRISPR reagents for therapeutic genome editing and new methods for off-target detection in cells and tissues.
Abstracts this author is presenting:
